FDBusiness.com

Nestlé Takes Stake in US Biopharmaceutical Company

 Breaking News
  • Hilton to Purchase 50% of Leading Vegetarian Manufacturer Hilton Food Group, the leading specialist international food packing business supplying major food retailers in Europe and Australia, has agreed to purchase a 50% shareholding in Dalco Food, a leading vegetarian product manufacturer based in Oss, the Netherlands. Hilton has agreed to enter into a joint venture agreement with Dalco’s shareholders, which includes an option [...]...
  • Great British Cheese Awards Winners Announced The winners of the Great British Cheese Awards have been announced. The Great British Cheese awards were established three years ago to celebrate the best of British cheese produced and distributed by independent cheese makers and retailers and this year, both established artisan brands and new cheesemakers have taken top awards. The category winners are: Artisan Producer – Tenacres, [...]...
  • Over 90% of Sampled Salt Brands Globally Found to Contain Microplastics Over 90% of sampled salt brands globally were found to contain microplastics, with the highest number coming from salt sourced in Asia, according to a new study co-designed by Kim, Seung-Kyu, Professor at Incheon National University and Greenpeace (www.Greenpeace.org) East Asia.[1] The study, which has been published in Environmental Science & Technology, a peer-reviewed scientific journal, [...]...
  • Ardgowan Unveils Plans For Inverclyde Distillery Ardgowan Distillery has revealed ambitious designs for its new £12 million distillery which is being built on the Ardgowan Estate near Inverkip, 30 miles west of Glasgow. The plans showcase the flagship building which has just secured revised planning consent from Inverclyde Council. The striking new design, by Michael Laird Architects, brings a number of improvements [...]...
  • HKScan Launches Exports of Finnish Poultry Products to Sweden HKScan, the Nordic food and meat group, has started exporting Finnish poultry products to Sweden. They will initially be sold through the largest retailer ICA’s outlets under the Karinäs®(Kariniemen®) brand. The launch gives Swedish consumers access to a new innovation: high welfare farm-born poultry that is hatched on the farm where it is raised. This new concept is [...]...

Nestlé Takes Stake in US Biopharmaceutical Company

Nestlé Takes Stake in US Biopharmaceutical Company
November 04
14:32 2016

Nestlé Health Science is to invest $145 million for a 15% stake in US-based Aimmune Therapeutics, a clinical-stage biopharmaceutical company developing treatments for life-threatening food allergies. The parties also entered into a strategic collaboration to accelerate the development of innovative oral immunotherapy biologics designed to desensitize people with food allergies and protect them from the consequences of accidental exposure.

Up to 250 million people globally are estimated to suffer from food allergies, between 5-8% of children and 1-2% of adults. Amongst the top eight food allergies, peanut allergy – generally a lifelong condition – is estimated to impact 6 million people in the US and in Europe or between 0.6 and 1.3% of the population in the US.

Aimmune’s Characterized Oral Desensitization ImmunoTherapy (CODIT™) approach to treating life-threatening food allergies is based on extensive independent scientific research demonstrating that most patients with food allergies can become desensitized to the allergens, or proteins, in a particular food through the oral administration of gradually increasing amounts of the allergens. It aims to provide a transformative treatment option that goes beyond the current standard of care of diligent avoidance of food allergens and carrying epinephrine for administration in case of accidental exposure.

NestleHealthScienceLicenseAgreementAimmune’s lead CODIT product candidate, AR101 for peanut allergy, is a characterized, regulated, oral biological drug product containing the protein profile found in peanuts designed to desensitize patients with peanut allergy. The ongoing Phase III trial, conducted by Aimmune, is expected to deliver results in 4Q2017, which – if positive – may support the filing of marketing authorization in the US and Europe. Per the terms of this collaboration agreement, Aimmune retains the rights to AR101 and all other pipeline assets developed with the CODIT approach.

The investment extends Nestlé Health Science’s interests in the food allergy arena. Nestlé Health Science already has an established portfolio of nutritional solutions for pediatric food allergy and intolerances, especially Cow’s Milk Protein Allergy (CMPA), as well as a simple, fast and easy-to-use awareness tool – CoMiSS® (Cow’s Milk-related Symptom Score) – which enables primary healthcare professionals to earlier recognize and assess symptoms that may be related to CMPA in infants. Earlier this year the company partnered with DBV Technologies on the development of a skin-patch test tool for the improved diagnosis of CMPA.

Greg Behar, chief executive of Nestlé Health Science, who will take a seat on the Aimmune Board, comments: “Food allergies have a huge personal impact and are a health economic burden. We are investing and innovating to change the approach to food allergy management with integrated approaches from diagnostics (Dx), to nutrition solutions (Nx) and now biologics (Rx), where Aimmune’s proprietary approach has transformational potential in lives of patients and families.”

The strategic investment launches a two-year strategic collaboration between Nestlé Health Science and Aimmune, the terms of which enable the parties to engage on Aimmune’s current and future oral immunotherapy development programs through a newly established pipeline forum. Nestlé Health Science will provide ongoing scientific, regulatory and commercial expertise and advice to Aimmune through the pipeline forum and in addition has a three-month exclusive right of first negotiation for any development program in the event Aimmune considers licensing or partnering such a program.

About Author

mike

mike

Related Articles



Food & Drink Business Conference & Exhibition 2016

Upcoming Events

  • October 21, 2018Int'l Food Products Exhibition (Sial)
  • October 25, 2018Italian Espresso Coffee Show (TriestEspresso Expo)
  • October 25, 2018Finnish Food Fair
  • October 31, 2018Int'l exhibition for food products and equipment (Indagra Food)
AEC v1.0.4

find food jobs

The Magazine

F&D Business Preferred Suppliers

New Subscriber





Subscribe Here



Advertisements